ANNX Annexon Inc

Price (delayed)

$22.04

Market cap

$844.84M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.63

Enterprise value

$770.5M

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on ...

Highlights
Annexon's EPS has surged by 98% YoY and by 95% QoQ
Annexon's quick ratio has soared by 200% YoY but it has decreased by 3.7% from the previous quarter
The company's net income has shrunk by 120% YoY and by 25% QoQ
The equity has declined by 8% since the previous quarter

Key stats

What are the main financial stats of ANNX
Market
Shares outstanding
38.33M
Market cap
$844.84M
Enterprise value
$770.5M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.86
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$96.14M
EBITDA
-$94.14M
Free cash flow
-$81.39M
Per share
EPS
-$1.63
Free cash flow per share
-$2.13
Book value per share
$7.72
Revenue per share
$0
TBVPS
$8.67
Balance sheet
Total assets
$331.78M
Total liabilities
$36.45M
Debt
$26.42M
Equity
$295.34M
Working capital
$294.11M
Liquidity
Debt to equity
0.09
Current ratio
29.6
Quick ratio
29.52
Net debt/EBITDA
0.79
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-29.4%
Return on equity
-30.9%
Return on invested capital
-88.5%
Return on capital employed
-29.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANNX stock price

How has the Annexon stock price performed over time
Intraday
1.8%
1 week
19.72%
1 month
16.06%
1 year
-1.91%
YTD
-11.95%
QTD
-2.09%

Financial performance

How have Annexon's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$96.3M
Net income
-$96.13M
Gross margin
N/A
Net margin
N/A
The company's operating income has shrunk by 125% YoY and by 25% QoQ
The company's net income has shrunk by 120% YoY and by 25% QoQ

Growth

What is Annexon's growth rate over time

Valuation

What is Annexon stock price valuation
P/E
N/A
P/B
2.86
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Annexon's EPS has surged by 98% YoY and by 95% QoQ
The equity has declined by 8% since the previous quarter
The P/B is 4.7% lower than the last 4 quarters average of 3.0

Efficiency

How efficient is Annexon business performance
The return on invested capital has grown by 48% since the previous quarter
The ROE is up by 16% since the previous quarter
ANNX's ROA is up by 14% YoY but it is down by 5% QoQ

Dividends

What is ANNX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANNX.

Financial health

How did Annexon financials performed over time
Annexon's quick ratio has soared by 200% YoY but it has decreased by 3.7% from the previous quarter
Annexon's current ratio has soared by 198% YoY but it has decreased by 4.2% from the previous quarter
Annexon's debt is 91% less than its equity
The equity has declined by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.